Check the status of reimbursement of modern cancer medicines in Poland

Oncoindex shows medicines registered by the European Medicines Agency (EMA)
in the past 15 years and recommended by the European Society for Medical Oncology (ESMO)

*
Or NCCN in the absence of current ESMO recommendations (older than 3 years).

The value on a scale from 0 to 100 demonstrates where we are in comparison with European standards of treatment.

Reimbursement status

Hide report
Poland
  • Poland
  • Spain
All tumors and diseases
  • All tumors and diseases
  • Solid tumours
  • Haemato-oncological diseases
Show the index for a particular cancer
  • Show data for current Oncoindex
  • non-Hodgkin lymphoma
  • Hodgkin’s disease
  • Acute lymphoid leukemia
  • Acute myeloid leukemia
  • Chronic lymphoid leukemia
  • Chronic myeloid leukemia
  • Malignant prostate cancer
  • Malignant ovarian cancer
  • Colon and rectum cancer
  • Kidney cancer
  • Malignant bladder cancer
  • Malignant breast cancer
  • Tracheal, bronchus, and lung cancer
  • Malignant pancreatic cancer
  • Liver cancer
  • Malignant stomach cancer
  • Multiple myeloma and plasma cell neoplasms

Total number of substances
recommended by ESMO:

Show the list of substances
Sorry, there was a problem downloading your data.

Oncoindex value compared to other countries

Hide report
Select countries you want to compare
  • Poland
  • Spain
Show the index for a particular cancer
  • Show data for current Oncoindex
  • non-Hodgkin lymphoma
  • Hodgkin’s disease
  • Acute lymphoid leukemia
  • Acute myeloid leukemia
  • Chronic lymphoid leukemia
  • Chronic myeloid leukemia
  • Malignant prostate cancer
  • Malignant ovarian cancer
  • Colon and rectum cancer
  • Kidney cancer
  • Malignant bladder cancer
  • Malignant breast cancer
  • Tracheal, bronchus, and lung cancer
  • Malignant pancreatic cancer
  • Liver cancer
  • Malignant stomach cancer
  • Multiple myeloma and plasma cell neoplasms
Sorry, there was a problem downloading your data.

Oncoindex review history

Hide report
Select countries you want to compare
  • Poland
  • Spain
Show the index for a particular cancer
  • Show data for current Oncoindex
  • non-Hodgkin lymphoma
  • Hodgkin’s disease
  • Acute lymphoid leukemia
  • Acute myeloid leukemia
  • Chronic lymphoid leukemia
  • Chronic myeloid leukemia
  • Malignant prostate cancer
  • Malignant ovarian cancer
  • Colon and rectum cancer
  • Kidney cancer
  • Malignant bladder cancer
  • Malignant breast cancer
  • Tracheal, bronchus, and lung cancer
  • Malignant pancreatic cancer
  • Liver cancer
  • Malignant stomach cancer
  • Multiple myeloma and plasma cell neoplasms
Select date from
  • March 2017
  • July 2018
  • November 2018
  • January 2019
  • May 2019
  • September 2019
  • January 2020
  • September 2020
  • January 2021
  • May 2021
  • September 2021
  • January 2022
  • May 2022
  • September 2022
  • January 2023
  • May 2023
  • September 2023
  • January 2024
  • April 2024
  • July 2024
  • October 2024
  • April 2025
Select date to
  • March 2017
  • July 2018
  • November 2018
  • January 2019
  • May 2019
  • September 2019
  • January 2020
  • September 2020
  • January 2021
  • May 2021
  • September 2021
  • January 2022
  • May 2022
  • September 2022
  • January 2023
  • May 2023
  • September 2023
  • January 2024
  • April 2024
  • July 2024
  • October 2024
  • April 2025
Sorry, there was a problem downloading your data.

Index for individual cancers

Hide report
Poland
  • Poland
  • Spain
Therapeutic area (cancer type) Index value Change in relation to previous survey
Show all
Sorry, there was a problem downloading your data.

Find out more about the Oncoindex methodology, concept and history

Discover Oncoindex